Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Teva Pharmaceutical Industries Ltd TEVA

Healthcare Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high... see more

Current News (NYSE:TEVA)

Teva Canada Announces Approval of Expanded Indication of [Pr]AJOVY® (fremanezumab solution for subcutaneous injection), the First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine

Canada NewsWire 11 days ago

Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential

GlobeNewswire January 28, 2026

Will Forte Teams Up with Teva to Get Real About Huntington's Disease with 'Honestly HD'

GlobeNewswire January 27, 2026

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

GlobeNewswire January 14, 2026

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation

GlobeNewswire January 11, 2026

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

GlobeNewswire January 11, 2026

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

GlobeNewswire January 11, 2026

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 5, 2026

S&P Global Ratings Upgrades Teva to 'BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive

GlobeNewswire December 24, 2025
View More News ››

Opinion & Analysis (NYSE:TEVA)

Gilead, Teva, XPhyto - Global marketing potential

Stockhouse Editorial June 16, 2020

The ASX: investing in an emerging biotech frontier

The Life Sciences Report August 10, 2016

An ETF That Provides Shelter From Stormy Markets

Benzinga.com  September 3, 2015

Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

George S. Mack September 3, 2015

Teva's Deal-Making Spurs Inflows To Israel ETFs

Benzinga.com  August 3, 2015

ETFs For The Next Pharma Takeover Candidates

Benzinga.com  July 28, 2015
View More Opinion ››

Bullboard Posts (NYSE:TEVA)

Opiates

<< View Post To Watch Video >>
Joe455 - December 30, 2021

Back in...

Lost a bit on this a few years ago, but bought back in this week at levels below what I had sold at, largely to crystalize the loss. I...
Paddy902 - April 28, 2019

CHECKOUT AVE.V ON THE VENTURE.STRONG WEDGE PATTERN BREAKOUT

STRONG US NUMBERS GOING INTO DRILLING SEASON
Charts1 - November 6, 2017

RE:Paths

Maybe yes, when it really does hit bottom, everyone is so offended they will not touch it anymore. Yet it trades 118M in a capitulation...
paths - November 4, 2017

Paths

You think it's hit the bottom yet? LMAO
rtftech16 - November 2, 2017

RE:RE:RE:RE:RE:RE:re: new position

Lmao keep trying to guess, your gettin warmer! Hahaha
rtftech16 - October 16, 2017
View more Bullboard ››

Nuclear Vision Ltd.

Nuclear Vision Ltd.

Nuclear Vision Limited operates as a uranium exploration company. Its material property is the Regnault Project that consists ...
View More »

Podcasts